Android app Apple app link

CytomX Therapeutics, Inc. (CTMX) Analyst Forecast

NASDAQ Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$4.56
Day's range
$5.05

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
03/18/2026 Jefferies Roger Song $16.00 $4.61   247.45%
03/16/2026 Oppenheimer Matthew Biegler $12.00 $8.03   49.53%
01/20/2026 Guggenheim Michael Schmidt $10.00 $5.39   85.53%
01/20/2026 Barclays Etzer Darout $8.00 $5.39   48.42%
10/21/2025 Barclays Etzer Darout $6.00 $3.74   60.43%
09/16/2025 Barclays Etzer Darout $3.50 $1.96   78.57%
07/31/2025 Oppenheimer Matthew Biegler $7.00 $2.32   201.72%
11/08/2024 BMO Capital Etzer Darout $3.68 $1.09   237.61%
11/08/2024 Piper Sandler Joseph Catanzaro $3.25 $1.09   198.17%
08/09/2024 BMO Capital Etzer Darout $3.56 $1.18   201.69%
05/27/2024 Piper Sandler Joseph Catanzaro $3.50 $1.75   100%
05/09/2024 BMO Capital Etzer Darout $3.59 $4.19   -14.32%
05/09/2024 Wedbush Robert Driscoll $8.00 $2.40   233.46%
05/05/2024 Jefferies Roger Song $8.00 $4.46   79.57%
03/12/2024 Jefferies Roger Song $2.50 $2.15   16.28%
03/12/2024 BMO Capital Etzer Darout $3.25 $2.15   51.16%

CytomX Therapeutics Inc FAQ's

CytomX Therapeutics Inc has been rated by research analysts at H.C. Wainwright, Jefferies, Oppenheimer, Barclays, Piper Sandler, Guggenheim in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.